TCR2 Therapeutics Inc. EBITDA 2019-2023 | TCRR
TCR2 Therapeutics Inc. ebitda from 2019 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| TCR2 Therapeutics Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-150 |
| 2021 | $-97 |
| 2020 | $-67 |
| 2019 | $-51 |
| 2018 | $-26 |
| 2017 | $-13 |
| 2016 | $-10 |
| TCR2 Therapeutics Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-03-31 | $-41 |
| 2022-12-31 | $-61 |
| 2022-09-30 | $-30 |
| 2022-06-30 | $-31 |
| 2022-03-31 | $-28 |
| 2021-12-31 | $-27 |
| 2021-09-30 | $-25 |
| 2021-06-30 | $-24 |
| 2021-03-31 | $-21 |
| 2020-12-31 | $-18 |
| 2020-09-30 | $-17 |
| 2020-06-30 | $-16 |
| 2020-03-31 | $-16 |
| 2019-12-31 | $-13 |
| 2019-09-30 | $-15 |
| 2019-06-30 | $-12 |
| 2019-03-31 | $-11 |
| 2018-12-31 | $-8 |
| 2018-09-30 | $-7 |
| 2018-06-30 | $-7 |
| 2018-03-31 | $-4 |
